secwatch.observer — SEC 8-K summary
======================================

Issuer:     RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK:        0001601830
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001601830-24-000076
Event type: other
Sentiment:  neutral
Materiality: 0.00
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Recursion annual meeting elects Class III directors, approves say-on-pay
------------------------------------------------------------------------

- Blake Borgeson, Ph.D. elected as Class III director with 165,914,956 votes for, 26,093,759 withheld.
- Dean Y. Li, M.D., Ph.D. elected as Class III director with 166,211,058 votes for, 25,797,657 withheld.
- Advisory resolution on executive compensation approved with 188,317,831 for, 2,887,180 against, 803,704 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601830/000160183024000076/0001601830-24-000076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601830/000160183024000076/rxrx-20240603.htm
  HTML page:      https://secwatch.observer/filing/0001601830-24-000076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer